首页 | 本学科首页   官方微博 | 高级检索  
     

ER、PR和Bcl-2在子宫内膜癌中的表达
引用本文:王艳丽,张晓霞,朱继红,刘宏晶. ER、PR和Bcl-2在子宫内膜癌中的表达[J]. 吉林大学学报(医学版), 2005, 31(2): 303-305
作者姓名:王艳丽  张晓霞  朱继红  刘宏晶
作者单位:吉林大学第一医院妇产科,吉林 长春130021
摘    要:目的:探讨ER、PR、Bcl-2在子宫内膜癌组织中的表达及临床意义。方法:对104例子宫内膜癌及另外30例癌旁正常组织石蜡标本用免疫组织化学的方法染色,检测ER、PR、Bcl-2的表达。结果:①子宫内膜癌中ER阳性表达率46.15%,PR阳性表达率65.38%,Bcl-2阳性表达率50.84%。癌旁正常组织中ER阳性表达率60.00%,PR阳性表达率66.66%,Bcl-2阳性表达率26.66%,两组比较Bcl-2表达差异有显著性(P<0.05),ER、PR表达差异无显著性;②PR的表达与Bcl-2表达呈正相关(r=0.216,P<0.05), ER的表达与Bcl-2表达无相关性;③在并发淋巴结转移的16例中ER阳性表达率50.00%,PR阳性表达率12.50%,Bcl-2阳性表达率25.00%,无淋巴结转移的88例ER阳性表达率45.45%,PR阳性表达率75.00%,Bcl-2阳性表达率59.09%,两组PR、Bcl-2阳性表达率比较差异有显著性(P<0.05), ER表达差异无显著性(P>0.05);④PR的表达在高分化腺癌与低分化腺癌间差异有显著性(P<0.05),高分化腺癌的阳性率高于低分化腺癌,ER、Bcl-2在子宫内膜高分化腺癌与低分化腺癌差异无显著性。结论:Bcl-2在子宫内膜癌中阳性表达率高,并与PR的表达呈正相关;淋巴结转移时PR、Bcl-2阳性表达率降低。PR、Bcl-2可以作为指示预后的因子。

关 键 词:受体  雌激素  受体  孕酮  原癌基因蛋白质c-bcl-2  免疫组织化学   
文章编号:1671-587X(2005)02-0303-03
收稿时间:2004-09-29
修稿时间:2004-09-29

Expressions of ER, PR, and Bcl-2 in endometrial carcinoma
WANG Yan-li,ZHANG Xiao-xia,ZHU Ji-hong,LIU Hong-jing. Expressions of ER, PR, and Bcl-2 in endometrial carcinoma[J]. Journal of Jilin University: Med Ed, 2005, 31(2): 303-305
Authors:WANG Yan-li  ZHANG Xiao-xia  ZHU Ji-hong  LIU Hong-jing
Affiliation:Department of Obstetrics and Gynecology, First Hospital, Jilin University, Changchun 130021, China
Abstract:Objective To determine the progesterone receptor (PR), estrogen receptor (ER), and Bcl-2 protein expressions in endometrial carcinoma and their clinical significances. Methods The expressions of PR, ER, and Bcl-2 in a total of 104 frozen tissues of endometrial carcinoma and 30 cases of paracarcinoma tissues were examined by immunohistochemistry. Results ①The expressions rates of PR, ER, and Bcal-2 protein in endometrial carcinoma were 65.38%, 46.15%, and 50.84%, respectively. They were 66.66%, 60.00%,and 26.66%, respectively, in parcarcinoma tissues. Statistically difference was found in the expressions of Bcl-2 between two groups (P<0.05), while it was not found in the expressions of ER and PR. ②Expression of PR was positively correlated with that of Bcl-2 (r=0.216,P<0.05). There was no relation between ER and Bcl-2. ③Positive expression rate of ER in 16 lymph node metastasis cases was 50.00%, those of PR and Bcl-2 were 12.50% and 25.00%,respectively. Positive expression rates of ER, PR, and Bcl-2 in 88 non lymph node metastasis cases were 45.45%, 75.00%,and 59.09%,respectively. Expressions of PR and Bcl-2 had statistically differences in the cases of lymph node metastasis or non-metastasis (P<0.05), while ER had not. ④Expression of PR was higher in highly differentiated endometrial adenocarcinoma than that in poorly differentiated one. Conclusion Positive expression rate of Bcl-2 in endometrial carcinoma is high, it is positively correlated with PR expression. PR and Bcl-2 positive expression rates in lymph node metastases cases are low. PR and Bcl-2 might be available prognostic factors.
Keywords:endometrial neoplasms  receptor  estrogen  receptor   progesterone  proto-oncogene proteins c-bcl-2  immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号